ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1411	National Cancer Institute	Html	en	Lung Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.	lung cancer screening 0.598829 beta-carotene cancer prevention 0.582664 Retinol Efficacy Trial 0.5493 World Cancer Research 0.557661 radiation-induced cancer risk 0.558005 Cancer Statistics Review 0.554669 Engl J Med 0.601423 lung cancer 0.940569 American Cancer Society 0.565044 new cancer cases 0.561841 cancer prevention study 0.562495 Lung cancer deaths 0.600217 Int J Cancer 0.549565 tobacco-specific lung carcinogen 0.591137 lung cancer survival 0.624991 lung cancers 0.566409 smoking-caused lung cancer 0.618173 Natl Cancer Inst 0.828608 increase lung cancer 0.607425 Clin Cancer Res 0.548805 lung cancer risks. 0.611661 et al. 0.610801 women 0.552318 lung cancer burden 0.611188 lung cancer risks 0.615545	Cancer Epidemiol Biomarkers 0.562574 Cancer Research Fund/American 0.55766 PUBMED Abstract 0.579028 cigarette smoking 0.565154 lung cancer rates 0.635876 National Cancer Institute 0.583038 high lung cancer 0.622636 primary lung cancer 0.607733 Abstract 0.640461 lung adenocarcinoma 0.566862 breast cancer 0.562844 5-year lung cancer 0.61828 breast cancer radiotherapy 0.549181 lung cancer. 0.565606 physical activity 0.552389 Carotene Cancer Prevention 0.55106 lung cancer risk 0.779552 Low-dose lung 0.559226 increases lung cancer 0.60774 lung cancer risk. 0.61153 Public Health Service 0.550531 lung cancer mortality 0.61452 lung cancer incidence 0.71571 air pollution 0.563747	CLICK HERE
1441	National Cancer Institute	Html	en	Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.	Italy Leukemia Group 0.492562 bcr-abl tyrosine kinase 0.570934 adults 0.459185 earlier marrow regeneration 0.455938 allogeneic bone marrow 0.517214 acute lymphoid leukemias 0.472448 remission induction 0.47757 Gale RP 0.454812 imatinib mesylate 0.472156 chemotherapy 0.474627 Engl J Med 0.498791 bone marrow transplantation 0.48642 tyrosine kinase inhibitors 0.483263 Rapid marrow ablation 0.456209 acute myeloid leukemia 0.613636 leukemia group 0.516396 Adult Leukemia Study 0.500665 acute lymphocytic leukemia 0.648415 reverse-transcriptase polymerase chain 0.482354 Burkitt leukemia 0.499236 chronic myeloid leukemia 0.493376 remission rate 0.456311 remission induction regimen 0.463491 polymerase chain reaction 0.48041	bone marrow transplant 0.489602 white blood cell 0.478936 different fusion protein 0.477591 chromosomal abnormalities 0.455367 bone marrow biopsy 0.472092 Abstract 0.51225 patients 0.592026 hairy cell leukemia 0.509021 Clin Oncol 0.480632 chronic myelogenous leukemia 0.543537 bone marrow 0.65205 Philadelphia chromosome 0.465482 complete response rate 0.474063 remission induction treatment 0.472074 acute lymphoblastic leukemia 0.938565 complete remission 0.520144 bcr-abl fusion gene 0.592307 acute leukemia 0.555648 complete remission status 0.464197 High complete remission 0.459577 marrow remission 0.460989 bone marrow transplants 0.462002 neutropenic cancer patients 0.462006	CLICK HERE
1580	National Cancer Institute	Html	en	Skin Cancer Screening (PDQ®)–Patient Version	Having a skin exam to screen for skin cancer has not been shown to decrease your chance of dying from skin cancer. Learn about this and other tests that have been studied to detect or screen for skin cancer in this expert reviewed summary.	PDQ Screening 0.323371 skin cancer 0.833312 cancer treatment 0.285886 cancer screening methods 0.360926 United States 0.282138 ongoing clinical trials 0.355632 screening tests 0.287638 cancer cells 0.293854 following PDQ summaries 0.338661 Cancer Information Service 0.328048 PDQ cancer information 0.497713 squamous cells 0.320712 squamous cell skin 0.32842 white men 0.281879 Prevention Editorial Board 0.34433 treatment clinical trials 0.288708 National Cancer Institute 0.431189 clinical trials 0.547197 PDQ documents 0.289835 inner layer 0.288892 test result 0.316842 cancer information summary 0.417477 melanoma skin cancer 0.385616 new treatment 0.294602	breast cancer prevention 0.311531 skin cancer screening 0.419518 Cancer screening trials 0.367401 NCI website 0.290521 Regular skin checks 0.306952 Cancer Care page 0.315809 PDQ database 0.293213 latest published information 0.29227 risk factor 0.309102 NCI’s PDQ 0.299274 PDQ summary 0.314752 UV radiation 0.308073 cancer symptoms 0.303698 doctor 0.289249 NCI PDQ cancer 0.373425 tests 0.320045 cancer information summaries 0.334989 nonmelanoma skin cancer 0.420432 comprehensive cancer information 0.335151 basal cell carcinoma 0.354359 cancer 0.95489 basal cells 0.2875 squamous cell carcinoma 0.357881	CLICK HERE
1635	National Cancer Institute	Html	en	Cancell/Cantron/Protocel (PDQ®)–Patient Version	Expert-reviewed information summary about the use of Cancell/Entelev as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	treatment 0.59635 peer-reviewed scientific journals 0.520434 cancer treatment 0.437142 cancer prevention 0.377301 Complementary Therapies Editorial 0.493039 United States 0.466761 Drug Administration 0.651254 Cancer Information Specialist 0.403618 cancer cells 0.478684 Cancer Information Service 0.547985 liquid mixture Cancell 0.377167 PDQ cancer information 0.676104 Cancer Complementary 0.434191 CAM therapies 0.389658 Cancell 0.664087 treatment clinical trials 0.370761 National Cancer Institute 0.97945 studies 0.373926 clinical trials 0.769435 alternative medicine 0.540927 U.S. Food 0.518657 conventional treatment 0.383649 health care 0.363873 cancer information summary 0.557509	scientific journals 0.541722 alternative cancer therapies 0.42141 Federal Trade Commission 0.393843 National Institutes 0.378494 clinical trial 0.410446 National Center 0.359319 CAM cancer research 0.395503 new treatment 0.357379 breast cancer prevention 0.372403 PDQ health 0.366183 cancer patients 0.43176 Cancer Care page 0.374735 health 0.389384 NCI’s PDQ 0.383229 PDQ summary 0.396491 Integrative Health 0.358164 NCI PDQ cancer 0.499567 cancer information database 0.420231 alternative therapies 0.478182 cancer information summaries 0.420966 Therapies Editorial Board 0.444837 research studies 0.372726 conventional treatments 0.361723	CLICK HERE
1693	National Cancer Institute	Html	null	Childhood Hematopoietic Cell Transplantation (PDQ®)–Health Professional Version	Blood and bone marrow transplantation involves the infusion of blood stem cells into a patient to reconstitute the blood system. Learn about transplant types, cell selection, and short- and long-term complications in this expert-reviewed summary.			CLICK HERE
1766	National Cancer Institute	Html	en	Accidents at Nuclear Power Plants and Cancer Risk	A fact sheet about cancer risks associated with accidents at nuclear power plants.	Atomic Radiation 0.316376 Radiation risks 0.325562 radiation exposures 0.328269 nuclear accident sites 0.293301 Radiation Research 0.323015 low levels 0.272065 nuclear power plant 0.97677 I-131 exposure 0.297263 radiation sickness 0.405841 high doses 0.352667 radiation emergencies 0.31438 Chernobyl nuclear power 0.302487 Additional radioactive isotopes 0.311741 dangerous radioactive isotopes 0.306851 cancer patients 0.299868 greatest cancer risks 0.294897 cancer risks 0.312758 radioactive materials 0.379547 radiation therapy 0.335122 unstable isotopes 0.274 Radiation Effects Research 0.350011 external radiation 0.312725 power plant disaster 0.278559 radioactive isotopes 0.53284 ionizing radiation 0.412892	health effects 0.355744 future nuclear accidents 0.300229 nuclear reactors 0.284713 power plant accident 0.397996 nuclear weapons explosions 0.282249 thyroid gland 0.292634 thyroid cancer 0.388789 radiation exposure 0.375545 power plant accidents 0.566854 Radiation Emergency Medical 0.344768 I-131 0.306486 radioactive exposure 0.273465 National Cancer Institute 0.340697 specific radioactive materials 0.295979 breast cancer risk 0.282358 Radiation Epidemiology Branch 0.341242 Chernobyl-related thyroid cancer 0.291023 radiation 0.697647 cancer risk 0.309268 et al 0.275755 medical x-ray machines 0.33168 cancer 0.423405 Chernobyl accident 0.42803 certain radioactive isotopes 0.3079	CLICK HERE
1918	National Cancer Institute	Html	es	Tratamiento del cáncer de vías biliares (colangiocarcinoma) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vías biliares.	pequeñas incisiones 0.429743 siguientes procedimientos 0.496942 pequeño número 0.430642 estadio iv 0.806715 IIIB.Estadio IIIA 0.428895 siguientes afecciones 0.443112 siguientes tipos 0.469726 múltiples tumores 0.426811 rayos x 0.429804 estadio ivb 0.620663 llama estadificación 0.509816 vías extrahepáticas distal 0.500664 rama derecha 0.425053 biliares extrahepáticas distal 0.562053 estadio iva 0.611281 quimioterapia sistémica 0.540152 National Cancer Institute 0.425091 quimioterapia sistémica ayuda 0.448855 colangiocarcinomas.ampliar anatomía 0.433411 estadios iiia 0.428062	siguientes riesgos 0.418955 estadio iib.estadio iia 0.483131 Instituto Nacional 0.443118 PDQ Tratamiento 0.452416 siguientes grupos 0.435798 vías biliares.Cáncer 0.522502 Colangiopancreatografía retrógrada 0.432583 marcador tumoral ca 0.457024 color arcilla 0.428813 fosfatasa alcalina 0.43337 siguientes factores 0.436523 partes distantes 0.435203 Physician Data Query 0.487514 estadio ib.estadio ia 0.481572 estadio iii 0.699586 antígeno carcinoembrionario 0.500245 biliar extrahepático distal 0.995606 medicamentos radiosensibilizadores 0.497933 pequeños conductos 0.46338 estadio ivb.estadio iva 0.489932	CLICK HERE
1975	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre lo que debe ser el cuidado desde los últimos días hasta las últimas horas de vida, esto incluye los síntomas comunes, dilemas éticos que podrían surgir, y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este tiempo.	palliative care experts 0.23431 with medical care 0.241191 discuss palliative care 0.233699 Symptom Assessment 0.232929 puntaje pps 0.250501 Chisholm G 0.239654 impending death 0.225195 American Cancer Society 0.325883 mioclonía inducida 0.230408 signos tardíos 0.255455 cancer care 0.288204 Cancer Patients Admitted 0.244551 Early palliative care 0.234581 Palliative Care Units 0.231229 cancer patients 0.700067 intensidad promedio 0.222271 Palliative Performance Scale 0.307144 PDQ Delirium 0.245083 respiración cheyne-stokes 0.226557 Symptom Assessment Scale 0.224548 End-of-Life Cancer Care 0.259456 hospitalized patients with 0.234983 patients with 0.788026 determinados pacientes 0.252968 Pain Symptom Manage 0.940988	care cancer 0.276344 delirium hiperactivo 0.272295 Santos R 0.261547 cohort study 0.227764 patients with metastatic 0.238354 Cancer Facts 0.237968 palliative care 0.397902 Morita T 0.262872 end-of-life discussion 0.224231 Hosp Palliat Care 0.228606 critical care setting 0.224616 treating delirium 0.237587 ill adult patients 0.223449 correlations with quality 0.226302 clinical signs 0.22445 canadian tertiary care 0.2263 Intern Med 0.224374 Clin Oncol 0.327109 Bruera E 0.232399 terminal care 0.223061 systematic review 0.239239 medical care 0.24121 spiritual care 0.22381 Care Med 0.223485	CLICK HERE
2048	National Cancer Institute	Html	es	Pruebas de Papanicolaou y del virus del papiloma humano (VPH)	Hoja informativa que describe los exámenes selectivos de detección del cáncer de cérvix, los cuales incluyen la prueba de Papanicolaou y la prueba de los virus del papiloma humano.	Lancet Oncology 0.30494 alta probabilidad 0.305241 Clinical Pathology 0.316699 siguientes categorías 0.313238 undergoing concurrent testing 0.307924 American Society 0.338185 Schiffman M 0.323335 pruebas conjuntas 0.308272 Sociedad Estadounidense 0.311719 Task Force Recommendation 0.307945 Preventive Services Task 0.350595 Cervical Pathology 0.322689 low-grade squamous 0.308742 Roche Molecular Systems 0.307924 Estados Unidos 0.346024 cervical cancer 0.362845 Clinical Pathology screening 0.309437 cobas hpv test 0.3092 PubMed Abstract 0.387591 categoría cin-2 0.304985 categoría cin-3 0.305133 human papillomavirus 0.356046 Cancer Journal 0.30689 atypical squamous cells 0.360558 Sistema Bethesda 0.324914	Patología Cervical 0.309863 lesiones asc-h 0.305566 categorías cin-2 0.305175 United States Preventive 0.309063 cuidado médico 0.306651 lesiones asc-us 0.30675 Katki HA 0.31204 alto riesgo 0.931083 clinical practice 0.304727 Drug Administration 0.304664 cervical cytology 0.30862 Servicios Preventivos 0.304816 Wacholder S 0.311753 resultado asc-us 0.312665 papillomavirus testing 0.305257 HPV cotesting 0.306351 resultados benignos 0.305213 Services Task Force 0.349973 cervical intraepithelial neoplasia 0.314986 mejores resultados 0.304652 Cancer Institute 0.314518 graves anomalías 0.316853 infecciones pasajeras 0.309673 squamous cell carcinoma 0.313148	CLICK HERE
3443	National Cancer Institute	Html	es	Prevención del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de labio, cavidad oral y orofaringe, y sobre las investigaciones dirigidas a prevenir esta enfermedad.	área pequeña detrás 0.802445 mastique betel 0.744682 Visuals Online 0.640815 voluntarios sanos 0.673012 rojo anormal 0.920245 Physician Data Query 0.914313 suficiente ejercicio 0.702729	prevención revisa 0.679375 siguientes tejidos 0.731332 PDQ Prevención 0.725434 National Cancer Institute 0.673463 siguientes riesgos 0.652028 Instituto Nacional 0.74458	CLICK HERE